These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 23407349)
21. Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report. Kato J; Okonogi H; Kanzaki G; Katsumata H; Nakada Y; Sagasaki M; Komine K; Ito K; Saito T; Matsunaga A; Tokutou K; Honda K; Tsuboi N; Yokoo T BMC Nephrol; 2024 May; 25(1):171. PubMed ID: 38769490 [TBL] [Abstract][Full Text] [Related]
22. A case of lipoprotein glomerulopathy with a rare apolipoprotein E isoform combined with neurofibromatosis type I. Takasaki S; Matsunaga A; Joh K; Saito T CEN Case Rep; 2018 May; 7(1):127-131. PubMed ID: 29356944 [TBL] [Abstract][Full Text] [Related]
23. A novel apolipoprotein E mutation caused by a five amino acid deletion in a Chinese family with lipoprotein glomerulopathy: a case report. Xie W; Xie Y; Lin Z; Xu X; Zhang Y Diagn Pathol; 2019 May; 14(1):41. PubMed ID: 31092271 [TBL] [Abstract][Full Text] [Related]
24. Lipoprotein glomerulopathy in China. Chen Y Clin Exp Nephrol; 2014 Apr; 18(2):218-9. PubMed ID: 24165683 [TBL] [Abstract][Full Text] [Related]
25. Four mutations (three novel, one founder) in TACSTD2 among Iranian GDLD patients. Alavi A; Elahi E; Tehrani MH; Amoli FA; Javadi MA; Rafati N; Chiani M; Banihosseini SS; Bayat B; Kalhor R; Amini SS Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4490-7. PubMed ID: 17898270 [TBL] [Abstract][Full Text] [Related]
26. A case report of youth-onset lipoprotein glomerulopathy with APOE Chicago mutation. Liu Y; Cheng Y; Wen Y; Li C; Chen G; Li M BMC Nephrol; 2024 Mar; 25(1):87. PubMed ID: 38448817 [TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E-related glomerular disorders. Saito T; Matsunaga A; Fukunaga M; Nagahama K; Hara S; Muso E Kidney Int; 2020 Feb; 97(2):279-288. PubMed ID: 31874799 [TBL] [Abstract][Full Text] [Related]
28. Common apolipoprotein E gene mutations contribute to lipoprotein glomerulopathy in China. Han J; Pan Y; Chen Y; Li X; Xing G; Shi J; Hou P; Zhang H; Wang H Nephron Clin Pract; 2010; 114(4):c260-7. PubMed ID: 20090368 [TBL] [Abstract][Full Text] [Related]
29. A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy. Chen S; Liu ZH; Zheng JM; Zhang X; Li LS J Nephrol; 2007; 20(5):568-75. PubMed ID: 17918142 [TBL] [Abstract][Full Text] [Related]
30. Lipoprotein glomerulopathy resulting from compound heterogeneous mutations of APOE gene: A case report. Li Y; Chen J; Zou Y; Wang W; Li G Medicine (Baltimore); 2022 Feb; 101(5):e28718. PubMed ID: 35119017 [TBL] [Abstract][Full Text] [Related]
31. A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy. Stratikos E; Chroni A Clin Exp Nephrol; 2014 Apr; 18(2):225-9. PubMed ID: 24149834 [TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia. Matsunaga A; Saito T Clin Exp Nephrol; 2014 Apr; 18(2):220-4. PubMed ID: 24570178 [TBL] [Abstract][Full Text] [Related]
33. Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy. Luo B; Huang F; Liu Q; Li X; Chen W; Zhou SF; Yu X Am J Nephrol; 2008; 28(2):347-53. PubMed ID: 18046082 [TBL] [Abstract][Full Text] [Related]
34. Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree. de Knijff P; van den Maagdenberg AM; Stalenhoef AF; Leuven JA; Demacker PN; Kuyt LP; Frants RR; Havekes LM J Clin Invest; 1991 Aug; 88(2):643-55. PubMed ID: 1864973 [TBL] [Abstract][Full Text] [Related]
35. Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: A review. Cambruzzi E; Pêgas KL J Bras Nefrol; 2019; 41(3):393-399. PubMed ID: 30421781 [TBL] [Abstract][Full Text] [Related]
36. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy. Mitani A; Ishigami M; Watase K; Minakata T; Yamamura T J Atheroscler Thromb; 2011; 18(6):531-5. PubMed ID: 21325775 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy. Qin Y; Sun XJ; Hu YF; Jing M; Yu XJ; Zhao MH; Tan Y Ren Fail; 2024 Dec; 46(1):2332491. PubMed ID: 38584145 [TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia. Solanas-Barca M; de Castro-Orós I; Mateo-Gallego R; Cofán M; Plana N; Puzo J; Burillo E; Martín-Fuentes P; Ros E; Masana L; Pocoví M; Civeira F; Cenarro A Atherosclerosis; 2012 Jun; 222(2):449-55. PubMed ID: 22481068 [TBL] [Abstract][Full Text] [Related]
39. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy. Ando M; Sasaki J; Hua H; Matsunaga A; Uchida K; Jou K; Oikawa S; Saito T; Nihei H Kidney Int; 1999 Oct; 56(4):1317-23. PubMed ID: 10504484 [TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy. Oikawa S; Matsunaga A; Saito T; Sato H; Seki T; Hoshi K; Hayasaka K; Kotake H; Midorikawa H; Sekikawa A; Hara S; Abe K; Toyota T; Jingami H; Nakamura H; Sasaki J J Am Soc Nephrol; 1997 May; 8(5):820-3. PubMed ID: 9176854 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]